Lymphoma Trial, Recruiting NCT06660446 Sponsor: Biogipuzkoa Health Research Institute Condition: Lymphoma
Back to Lymphoma

Lymphoma Trial, Recruiting

NCT06660446
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with lymphoma, confirmed by tissue testing, and who need systemic treatment including chemotherapy
  • People who have 80 minutes available, two days per week, for 20 weeks to attend physical exercise sessions
  • People who own a mobile phone that can be used for contact and to download a physical activity app
  • People whose general physical functioning is rated at a certain level by their doctor (known as ECOG performance status of 2 or below — confirm with trial site)
  • People with a life expectancy of more than 12 months
  • People who are willing and available to take part for the full duration of the study

Who may not be able to join:

  • People for whom moderate-to-high intensity exercise has been medically ruled out
  • People with other significant health conditions, including long-term or recurring psychiatric illness, intellectual disability, musculoskeletal problems, heart or lung conditions that would interfere with exercise, another cancer diagnosed within the last five years (except certain skin cancers that have been treated and are under control), or any other illness that could be worsened by physical exercise
  • People who plan to be away from their city for more than two weeks during the study period
  • People who are already meeting the World Health Organization's physical activity recommendations (more than 150 minutes of moderate exercise per week, plus strength training two days per week)
  • People whose lymphoma treatment involves immunotherapy only, with no other treatment types
  • People whose lymphoma has spread to the central nervous system (the brain or spinal cord)
  • People with any significant personal or medical history that would limit their ability to fully participate in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Izaskun Zeberio Etxetxipia, Hospital Donostia

Phone: +34943006140

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Biogipuzkoa Health Research Institute
Registry
ClinicalTrials.gov
Start date
8 October 2024
Est. completion
30 March 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Cardiorespiratory fitness (CRF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov